Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease
2023 · Annals of Clinical Microbiology and Antimicrobials · 13 citations
https://doi.org/10.1186/s12941-023-00560-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
304
Citations
10
h-index
11
i10-index
Bing Yu is an academic researcher from Inner Mongolia Electric Power (China). The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Long-Term Effects of COVID-19. The author has an h-index of 10, co-authored 28 publications.
ORCID: 0000-0003-4365-2140Click to start Chat